SAFC announced its new aggressive growth strategy, including plans to expand in the developing markets, at its conference in Irvine, Glasgow last week.
The firm has made around $100m (€73m) worth of investments over the past 18 months, including upgrades in fermentation at their plant in Israel, as well as developments in their packaging and QC sectors in India, China and Brazil.
When president Gilles Cottier spoke to Outsourcing-Pharma, he said that the company– who focus on custom-manufacturing, custom-packaging and customized raw-material supply services within Sigma-Aldrich – is now expanding in two main markets; biopharmaceuticals, and electronics.
And as part of plans to expand in the BRIC market (Brazil, Russia, India, China) Cottier also spoke of new supply chain management measurements.
He also discussed SAFC’s expanded capabilities in media manfucaturing, including a focus on liquid media capabilities at the Irvine facility.